C&EN12h
50 new drugs received FDA approval in 2024
The US Food and Drug Administration approved 50 new molecular entities in 2024 —just five fewer than it did in 2023. Last ...
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...
EQS-News: Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara®
Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Otulfi ® approved by Health Canada for both subcutaneous and intravenous ...
FDA approves injectable version of Bristol Myers Squibb's cancer drug Opdivo
By Sneha S K and Sriparna Roy (Reuters) - The U.S. Food and Drug Administration said on Friday that it has approved an ...
Yahoo News UK15d
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
The FDA has announced that popular weight loss medication tirzepatide is no longer in shortage, potentially removing cheaper versions of the drug from the market by early 2025. Tirzepatide is the ...
NBC New York16d
FDA says the Zepbound shortage is over. Here's what that means for compounding pharmacies, patients who used off-brand versions
The Food and Drug Administration announced that branded tirzepatide, the active ingredient in Eli Lilly's weight loss drug Zepbound, is no longer in short supply. That decision will largely ...
Everyday Health17d
FDA Says Shortages of GLP-1 Drugs Mounjaro and Zepbound Are Over
many sold by online pharmacies, will no longer be allowed. Semaglutide, the main ingredient in Ozempic and Wegovy, is in ongoing shortage, the FDA says, and compounded versions of these drugs are ...
C&EN18d
Shortages created opportunities for counterfeits
Compounders have a role to play in legitimate drug supply, Davis says; they periodically fill in shortfalls of FDA-approved drugs, such as a pediatric antibiotic infusion that was in short supply ...
WCVB Channel 5 Boston19d
FDA says knockoff versions of Lilly obesity drug must come off the market
Specialty pharmacies ... pressing the FDA to take the step for months — and is expected to impact how patients access the drugs, including how much they pay.Zepbound is FDA-approved to treat ...
Newswire19d
National Bank receives final approval to proceed with the acquisition of Canadian Western Bank
Minister of Finance approves National Bank's acquisition of Canadian Western Bank. Approval concludes the regulatory process, following reviews by the Office of the Superintendent of Financial ...